September 3rd 2024
The updated COVID-19 vaccine targets the currently circulating Omicron variant JN.1 strain of SARS-CoV-2.
August 23rd 2024
Topics include declining vaccine coverage among kindergarten-aged children and key changes in recommendations for adult vaccination.
Now that the WHO has declared a second mpox global emergency, you may want to brush up on knowledge of the disease and the 2024 outbreak.
August 22nd 2024
The updated COVID-19 vaccines will include a monovalent component corresponding to KP.2, a strain of the Omicron variant of SARS-CoV-2.
August 19th 2024
The First to Know Syphilis Test detects a current or past infection, regardless of successful treatment, in 15 minutes using a drop of blood.
Patient, Provider, and Caregiver Connection™: Prevention and Control of Meningococcal Disease — Individualizing Vaccine Recommendations in Adolescent Populations
View More
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 20, 2021
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 19, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 16, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 15, 2021
New Evidence Reveals Most Common Long-term COVID-19 Symptoms among Health Care Workers
Fatigue was among the most common symptoms that health care workers in Sweden reported 8 months after mild COVID-19 infection, according to a new research letter.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 14, 2021
Single Injection of Monoclonal Antibodies Reduces Risk of Symptomatic SARS-CoV-2 Infection
A single injection of casirivimab and imdevimab reduced the risk for symptomatic SARS-CoV-2 infection by 81% among household contacts of infected persons, according to new phase 3 study results.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 13, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 12, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 9, 2021
Global confirmed cases of COVID-19 have surpassed 134 million. Plus more data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 8, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 7, 2021
COVID-19 Death Rates Far Higher for Black Women vs Men in Other Racial Groups, Suggest Harvard Researchers
Black women in the US are dying from COVID-19 at a higher rate than every other sex and racial group, except Black men, according to a new study.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 6, 2021
ACP Guidance on Antibiotic Use: 4 Conditions Ideal for Short-course Treatment
Longer antibiotic treatment courses can often be safely and effectively shortened, according to the ACP guidance; 4 common conditions serve as examples.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 5, 2021
FDA Increased the Maximum Doses per Vial for Moderna COVID-19 Vaccine
In an April 1, 2021 statement, the FDA announced the authorization of a new multi-dose vial of Moderna's COVID-19 vaccine that contains up to 15 doses.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 2, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 1, 2021
Pfizer-BioNTech COVID Vaccine Efficacy High at 6 Months, Companies Report
The COVID-19 vaccine partners announced an efficacy rate of >90% for BNT162b2 among 12 000 trial participants at up to 6 months after the second dose.
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of March 31, 2021
Pfizer-BioNTech COVID-19 Vaccine Found 100% Effective in Younger Teens
Pfizer-BioNTech announced today the complete protection against infection with SARS-CoV-2 among youth aged 12 to 15 years.
SARS-CoV-2 Variants: How Many and How Dangerous?
The CDC defines 3 classes of SARS-CoV-2 variants: Variants of interest, of concern, and of high consequence. Find out more about the 8 variants now being closely observed.
COVID-19 Updates: US and Global Cases, Deaths, and Vaccinations as of March 30, 2021
COVID-19: Bamlanivimab-Etesevimab Antibody Cocktail Reduces Risk of Hospitalization, Death
New data suggests that the antibody cocktail, bamlanivimab plus etesevimab, reduces the risk of COVID-19-related hospitalizations and death by 87% in high-risk COVID-19 patients.
COVID-19 Updates: US and Global Cases, Deaths, and Recoveries as of March 29, 2021
COVID-19 Updates: US and Global Cases, Deaths, and Recoveries as of March 26, 2021
US confirmed cases of COVID-19 have surpassed 30 million; global cases have reached 125 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
CDC Guidance for Fully Vaccinated Persons: Part 2
In part 2 of our series on the CDC guidance, find questions you may be asked by patients about quarantine and testing, and the answers to help prepare.
COVID-19 Updates: US and Global Cases, Deaths, and Recoveries as of March 25, 2021
Novel Study Finds Mild COVID-19 Associated with Prominent, Persistent Neurologic Symptoms
Brain fog topped the list of neurological symptoms in patients with long-haul COVID-19 whose illness was not severe enough to warrant hospitalization, according to a novel study.